{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:08:08Z","timestamp":1791616088050,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["DoD- W81XWH-17-BCRP"],"award-info":[{"award-number":["DoD- W81XWH-17-BCRP"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Veterans Health Administration Rehabilitation Research &amp; Development Service","doi-asserted-by":"publisher","award":["VA-ORD BX004974"],"award-info":[{"award-number":["VA-ORD BX004974"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006800","name":"Honorable Tina Brozman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.celrep.2021.110146","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T14:00:57Z","timestamp":1640700057000},"page":"110146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis"],"prefix":"10.1016","volume":"37","author":[{"given":"Nur","family":"Yucer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Ahdoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Laperle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8064-9381","authenticated-orcid":false,"given":"Maria S.","family":"Recouvreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-7859","authenticated-orcid":false,"given":"Kathleen","family":"Kurowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Naboulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7263-350X","authenticated-orcid":false,"given":"Jasmine T.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Gayther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-8721","authenticated-orcid":false,"given":"Sandra","family":"Orsulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-2933","authenticated-orcid":false,"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.110146_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6601603","article-title":"Predicting biomarkers for ovarian cancer using gene-expression microarrays","volume":"90","author":"Adib","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib2","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gr.133744.111","article-title":"Detecting differential usage of exons from RNA-seq data","volume":"22","author":"Anders","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.celrep.2021.110146_bib3","first-page":"150","article-title":"High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer","volume":"60","author":"Anttila","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.110146_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.5966\/sctm.2014-0121","article-title":"Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines","volume":"3","author":"Barrett","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.celrep.2021.110146_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ijgc-00009577-200511001-00015","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib6","first-page":"149","article-title":"Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression","volume":"8","author":"Behrens","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.celrep.2021.110146_bib7","doi-asserted-by":"crossref","first-page":"e0120020","DOI":"10.1371\/journal.pone.0120020","article-title":"Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1\/2 mutation carriers","volume":"10","author":"Blanco","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2021.110146_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2021.110146_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nsmb.1831","article-title":"53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers","volume":"17","author":"Bouwman","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2021.110146_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-017-0360-1","article-title":"Increased RHAMM expression relates to ovarian cancer progression","volume":"10","author":"Buttermore","year":"2017","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.celrep.2021.110146_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/32688","article-title":"Mutations of mitotic checkpoint genes in human cancers","volume":"392","author":"Cahill","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110146_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110146_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2021.110146_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10735-014-9607-y","article-title":"Expression and clinical role of TCTP in epithelial ovarian cancer","volume":"46","author":"Chen","year":"2015","journal-title":"J.\u00a0Mol. Histol."},{"key":"10.1016\/j.celrep.2021.110146_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2015.00245","article-title":"The Extracellular Matrix in Epithelial Ovarian Cancer\u2014A Piece of a Puzzle","volume":"5","author":"Cho","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41379-020-00648-y","article-title":"Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma","volume":"34","author":"Chui","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2021.110146_bib18","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/ijms19092512","article-title":"Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer","volume":"19","author":"Coan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2021.110146_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nm.4355","article-title":"Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing","volume":"23","author":"Crespo","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110146_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4252\/wjsc.v7.i2.461","article-title":"Using induced pluripotent stem cells as a tool for modelling carcinogenesis","volume":"7","author":"Curry","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.celrep.2021.110146_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13048-019-0577-2","article-title":"Organoids of epithelial ovarian cancer as an emerging preclinical in\u00a0vitro tool: a review","volume":"12","author":"Dumont","year":"2019","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.celrep.2021.110146_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.celrep.2021.110146_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Felder","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13048-019-0508-2","article-title":"Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis","volume":"12","author":"Feng","year":"2019","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.celrep.2021.110146_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","article-title":"BRCA1 mutations in primary breast and ovarian carcinomas","volume":"266","author":"Futreal","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110146_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-018-0424-x","article-title":"DNA damage repair in ovarian cancer: unlocking the heterogeneity","volume":"11","author":"Gee","year":"2018","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.celrep.2021.110146_bib27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3892\/or.2012.1641","article-title":"53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway","volume":"27","author":"Hong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.celrep.2021.110146_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2021.110146_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fonc.2013.00217","article-title":"Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms","volume":"3","author":"Jones","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib30","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/en.2014-1977","article-title":"The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2021.110146_bib31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110146_bib32","doi-asserted-by":"crossref","first-page":"934261","DOI":"10.1155\/2014\/934261","article-title":"Recent concepts of ovarian carcinogenesis: type I and type II","volume":"2014","author":"Koshiyama","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.celrep.2021.110146_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/diagnostics7010012","article-title":"Subtypes of ovarian cancer and ovarian cancer screening","volume":"7","author":"Koshiyama","year":"2017","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.celrep.2021.110146_bib34","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2021.110146_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.celrep.2021.110146_bib36","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110146_bib38","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot078071","article-title":"The cleared mammary fat pad transplantation assay for mammary epithelial organogenesis","volume":"2015","author":"Lawson","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.celrep.2021.110146_bib78","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","article-title":"Modeling familial cancer with induced pluripotent stem cells","volume":"161","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110146_bib40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13048-018-0467-z","article-title":"Identification of core genes in ovarian cancer by an integrative meta-analysis","volume":"11","author":"Li","year":"2018","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.celrep.2021.110146_bib41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00404-015-3904-x","article-title":"PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis","volume":"293","author":"Liu","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.celrep.2021.110146_bib42","doi-asserted-by":"crossref","first-page":"dev156166","DOI":"10.1242\/dev.156166","article-title":"Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.celrep.2021.110146_bib43","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110146_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1309\/AJCPIDKDLSGE26CX","article-title":"Expression and prognostic significance of APE1\/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer","volume":"141","author":"Londero","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.celrep.2021.110146_bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110146_bib46","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110146_bib47","doi-asserted-by":"crossref","first-page":"e0174037","DOI":"10.1371\/journal.pone.0174037","article-title":"Increased expression of protein kinase CK2\u03b1 correlates with poor patient prognosis in epithelial ovarian cancer","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2021.110146_bib48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ncomms2378","article-title":"Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells","volume":"4","author":"Mae","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110146_bib49","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/0008-5472.850.65.3","article-title":"Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity","volume":"65","author":"Maxwell","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.110146_bib50","doi-asserted-by":"crossref","first-page":"e1001199","DOI":"10.1371\/journal.pbio.1001199","article-title":"Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer","volume":"9","author":"Maxwell","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2021.110146_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.celrep.2021.110146_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.110146_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/ijms22031227","article-title":"iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression","volume":"22","author":"Portier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2021.110146_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib55","doi-asserted-by":"crossref","first-page":"e0126633","DOI":"10.1371\/journal.pone.0126633","article-title":"Expression of the Carboxy-Terminal Portion of MUC16\/CA125 Induces Transformation and Tumor Invasion","volume":"10","author":"Rao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2021.110146_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B","article-title":"Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers","volume":"87","author":"Russell","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib57","first-page":"381080","article-title":"Role of CEACAM1, ECM, and mesenchymal stem cells in an orthotopic model of human breast cancer","volume":"2011","author":"Samineni","year":"2011","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.celrep.2021.110146_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2021.110146_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","article-title":"Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery","volume":"26","author":"Sharma","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2021.110146_bib60","doi-asserted-by":"crossref","first-page":"102242","DOI":"10.1016\/j.scr.2021.102242","article-title":"Generation and characterization of induced pluripotent stem cells from a family carrying the BRCA1 mutation c.3612delA","volume":"52","author":"Silva","year":"2021","journal-title":"Stem Cell Res. (Amst.)"},{"key":"10.1016\/j.celrep.2021.110146_bib61","doi-asserted-by":"crossref","first-page":"102364","DOI":"10.1016\/j.scr.2021.102364","article-title":"Generation and characterization of induced pluripotent stem cells heterozygous for the Portuguese BRCA2 founder mutation","volume":"53","author":"Silva","year":"2021","journal-title":"Stem Cell Res. (Amst.)"},{"key":"10.1016\/j.celrep.2021.110146_bib62","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.stemcr.2013.08.004","article-title":"Analysis of induced pluripotent stem cells from a BRCA1 mutant family","volume":"1","author":"Soyombo","year":"2013","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.celrep.2021.110146_bib63","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.110146_bib64","doi-asserted-by":"crossref","first-page":"42983","DOI":"10.18632\/oncotarget.17785","article-title":"Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2021.110146_bib65","first-page":"3815","article-title":"Loss of tubal ciliated cells as a risk for \u201covarian\u201d or pelvic serous carcinoma","volume":"10","author":"Tao","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.celrep.2021.110146_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.stemcr.2014.05.007","article-title":"Comparable generation of activin-induced definitive endoderm via additive Wnt or BMP signaling in absence of serum","volume":"3","author":"Teo","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.celrep.2021.110146_bib67","doi-asserted-by":"crossref","first-page":"101851","DOI":"10.1016\/j.scr.2020.101851","article-title":"Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936","volume":"46","author":"Toombs","year":"2020","journal-title":"Stem Cell Res. (Amst.)"},{"key":"10.1016\/j.celrep.2021.110146_bib68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.celrep.2021.110146_bib69","first-page":"408","article-title":"Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system","volume":"66","author":"Voltaggio","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2021.110146_bib70","first-page":"E89","article-title":"Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.110146_bib71","first-page":"2082","article-title":"Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis","volume":"7","author":"Wang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.celrep.2021.110146_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2014.12.001","article-title":"ATM and ATR as therapeutic targets in cancer","volume":"149","author":"Weber","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2021.110146_bib73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2001.6280","article-title":"Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium","volume":"82","author":"Wong","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.celrep.2021.110146_bib74","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2021.110146_bib75","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1038\/s41598-017-05519-2","article-title":"Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium","volume":"7","author":"Yucer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.110146_bib76","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/s41467-019-10570-w","article-title":"Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion","volume":"10","author":"Zaoui","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110146_bib77","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721016429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721016429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:45:44Z","timestamp":1778841944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721016429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":78,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2211124721016429"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110146","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741384930.793590840","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"110146"}}